Skip to main content
. 2012 Nov 5;7(11):e47764. doi: 10.1371/journal.pone.0047764

Table 2. Phenotype characteristics of BM-MSCs (n = 11).

Surface markers Control (%) AA (%)
CD34 - -
CD45 - -
CD73 99.71±0.16 99.55±0.03
CD105 87.45±5.19 75.88±22.28
CD90 83.77±1.85 89.55±1.95
CD44 99.63±0.06 99.61±0.11
CD29 99.52±0.17 99.64±0.07
CD49e 98.18±0.66 98.68±0.7
CD166 94.09±3.99 85.72±8.11
HLA-ABC 99.71±0.16 99.71±0.16
HLA-DR - -